Rohto Pharmaceutical Co., Ltd. operates within the Toilet preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Rohto Pharmaceutical Co., Ltd. with three other
companies in this sector in Japan:
Rizap Group Inc
sales of 95.30 billion Japanese Yen [US$861.51 million]
of which 40%
was Health & Beauty-Related Businesses),
(94.64 billion Japanese Yen [US$855.55 million]
of which 34%
was Domestic Baby Mother), and
(96.31 billion Japanese Yen [US$870.60 million]
of which 59%
was Cosmetics Business).
During the year ended March of 2017, sales at
Rohto Pharmaceutical Co., Ltd. were ¥154.60 billion (US$1.40 billion).
decrease of 7.4%
versus 2016, when the company's sales were ¥167.02 billion.
Contributing to the drop in overall sales was the 18.8% decline
in Operating Segment-Asia, from ¥51.62 billion to ¥41.90 billion.
There were also decreases in sales in
Operating Segment-Japan (down 0.1% to ¥96.88 billion)
Operating Segment-Europe (down 12.3% to ¥7.03 billion)
Operating Segment-America (down 17.6% to ¥6.91 billion)
Operating Segment-Other (down 9.1% to ¥1.88 billion)